FENC FY 2020 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

FENCFennec Pharmaceuticals Inc.

$216M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$170,000

Gross Profit

$170,000100.0% margin

Operating Income

-$18M-10520.6% margin

Net Income

-$18M-10652.4% margin

EPS (Diluted)

$-0.76

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$31M

Total Liabilities

$2M

Stockholders' Equity

$29M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$170,000	$0	—
Gross Profit	$170,000	$0	—
Operating Income	-$18M	-$13M	-34.4%
Net Income	-$18M	-$13M	-38.5%